The purpose of the present study is to identify if the expression level of p-Ser9-GSK-3β is an effective prognostic factor for HCC patients and learn more about the interaction among the T2DM, expression of p-Ser9-GSK-3β and the prognosis of HCC. This evidence concerns the gene GSK3B and hepatocellular carcinoma.